NRx Pharmaceuticals, Inc.
NASDAQ:NRXP · NASDAQ Global Market
-$0.08 today
Vol 0.55M · Avg 1.28M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+18.86%
Period High
$4.62
Period Low
$1.68
Latest
$3.97
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Karyopharm Therapeutics Inc.
NASDAQ:KPTI
$215.30M
Century Therapeutics, Inc.
NASDAQ:IPSC
$194.78M
Equillium, Inc.
NASDAQ:EQ
$99.82M
Spruce Biosciences, Inc.
NASDAQ:SPRB
$71.19M
Cue Biopharma, Inc.
NASDAQ:CUE
$64.46M
Coeptis Therapeutics, Inc.
COEP
$57.63M
Outlook Therapeutics, Inc.
NASDAQ:OTLK
$50.19M
Senti Biosciences, Inc.
SNTI
$25.24M
Werewolf Therapeutics, Inc.
HOWL
$18.52M
IO Biotech, Inc.
IOBT
$885,690.00
What is the latest NRXP filing?
The latest filing shown is 8-K dated Jun 4, 2026.
How many recent filings does NRXP have?
Intrinsic Alpha currently shows 20 recent filings for NRXP.
Explore More
Continue the stock analysis
Jump to another research area for this company.